Table 2 Experimental plan for test animals and control
Groups | Experimental plan | Remarks |
|---|---|---|
Group 1, 2, 3 | Were infected with Plasmodium berghei and administered with Morinda lucida plant extract at 400, 600, and 800 mg/kg body weight, respectively, for 5 consecutive days | Treatment |
Group 4, 5, 6 | Were infected with Plasmodium berghei and treated with Alstonia boonei plant extract at 400, 600, and 800 mg/kg body weight, respectively, for 5 consecutive days | Treatment |
Group 7, 8, 9 | Were infected with Plasmodium berghei and treated with combined recipe of Morinda lucida and Alstonia boonei extract at 400, 600, and 800 mg/kg body weight, respectively, for 5 consecutive days | Combined treatment |
Groups 10 | Were infected with Plasmodium berghei and treated with 10 mg/kg of chloroquine phosphate solution for 5 consecutive days | Drug treatment control |
Group 11 | Were infected with Plasmodium berghei and only given 5 ml/kg of distilled water | Positive control |
Groups 12 | Were administered with 800 mg/kg body weight of Morinda lucida plant extract for 5 consecutive days. | Plant extract control |
Groups 13 | Were administered with 800 mg/kg body weight of Alstonia boonei plant extract for 5 consecutive days. | Plant extract control |
Group 14 | Were administered with 800 mg/kg body weight of combined Morinda lucida and Alstonia boonei extract for 5 consecutive days. | Plant extract control |
Group 15 | Were neither infected nor treated | Negative control |